| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,863 |
6,722 |
$635K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,503 |
5,612 |
$573K |
| S9083 |
Global fee urgent care centers |
1,183 |
1,094 |
$467K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,805 |
4,227 |
$409K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,008 |
4,722 |
$395K |
| 99401 |
|
8,597 |
7,161 |
$256K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
11,425 |
9,365 |
$144K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,472 |
3,949 |
$121K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
730 |
715 |
$75K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,547 |
1,437 |
$52K |
| 99201 |
|
235 |
222 |
$18K |
| 36410 |
|
783 |
742 |
$15K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
142 |
136 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
119 |
118 |
$12K |
| 93923 |
|
81 |
81 |
$9K |
| 90674 |
|
342 |
341 |
$8K |
| 90756 |
|
241 |
238 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
834 |
807 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
40 |
40 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
230 |
180 |
$2K |
| 97799 |
|
40 |
13 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
83 |
79 |
$1K |
| 0002A |
|
42 |
42 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
48 |
43 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
87 |
86 |
$1K |
| 90686 |
|
46 |
46 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
130 |
129 |
$592.75 |
| 93000 |
|
105 |
99 |
$396.19 |
| 0001A |
|
42 |
41 |
$358.92 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
25 |
25 |
$157.76 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
20 |
20 |
$45.48 |
| 82962 |
|
79 |
76 |
$29.85 |
| 82948 |
|
25 |
25 |
$4.04 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
41 |
40 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
43 |
42 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
31 |
30 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
30 |
28 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
30 |
28 |
$0.00 |
| 99072 |
|
13 |
13 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
12 |
12 |
$0.00 |